Case Management for Latent TB Infection
Description:
Training Date: Thursday, December 9, 2021 [virtual training offered via Zoom]
Ending TB in the Last Frontier
Description:
Faculty: Lisa Chen, MD | Neha Shah, MD, MPH | Donna Fearey, ANP, MSN | Michelle Rothoff, MD | Bruce Chandler, MD | Willy Mamtchueng, RN, BSN
Spokane TB Clinical Intensive
Description:
~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~
Basics of MDR-TB Clinical Care: Online Video Series
The Basics of MDR-TB Clinical Care: Online Video Series is comprised of a series of short, online lectures presented in easy to digest segments. The first five installments are now available and the complete series will cover major topics pertaining to epidemiology, diagnosis, treatment regimens, monitoring and case management, side-effects, prevention and isolation, treatment of contacts, and special situations.
Date of Release: December 2017 - March 2020
Practical Implementation of the 2016 ATS/CDC/IDSA Treatment Of Drug Susceptible Tuberculosis Guidelines: Caveats and Controversies
Description:
Facilitator: David Ashkin, MD, FCCP
Panelists: Peter Davidson, PhD | Susan E. Dorman, MD | Alfred Lardizabal, MD | Phil LoBue, MD | Barbara Seaworth, MD | John Wilson, MD | Patty Woods, RN
Panelists: Peter Davidson, PhD | Susan E. Dorman, MD | Alfred Lardizabal, MD | Phil LoBue, MD | Barbara Seaworth, MD | John Wilson, MD | Patty Woods, RN
Difficult Dilemmas and Cutting Edge Solutions: Advanced Topics in TB
Description:
Faculty: Gwen Alcazar, RN, PHN, BA | Pennan Barry, MD, MPH | C. Robert Horsburgh, Jr., MD, MUS | Paul Jensen, PHD, PE, CIH | Charles Peloquin, PharmD, FCCP | Lisa True, RN, MS
2016 ATS/CDC/IDSA Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis Webinar
Description:
Faculty: Dick Menzies, MD | Payam Nahid, MD, MPH
Facilitator: Lisa Chen, MD
Panelists: David Ashkin, MD, FCCP | Susan E. Dorman, MD | Andrew Vernon, MD, MHS
INH and Rifapentine Treatment for LTBI: Expert Opinions About 3HP Utilization
Description:
Faculty: Heidi Behm, RN, MPH | Marcos Burgos, MD | Neha Shah, MD, MPH | Mai Vu, Pharm D
Drug-Resistant Tuberculosis: A Survival Guide for Clinicians, 3rd edition
First released in 2004, the Guide is a joint publication of CITC and the Tuberculosis Control Branch of the California Department of Public Health. It contains information and user-friendly tools and templates for use by any clinician who participates in the management of patients with drug-resistant TB.
The 10 chapters and 4 appendices cover major topics pertaining to epidemiology, diagnosis, laboratory issues, treatment, medications, pediatrics, co-morbidities and special situations, monitoring and case management, adverse reactions, and treatment of contacts.
Directly Observed Therapy Training Curriculum for TB Control Programs
This training curriculum was developed to improve the skills of DOT workers in public health TB control programs. It is targeted to TB controllers, program managers, health educators and others who train DOT staff. This skill-based curriculum addresses the following topics: